Canlyniadau Chwilio - Xiuhua Fu

  • Dangos 1 - 3 canlyniadau o 3
Mireinio'r Canlyniadau
  1. 1
    Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706)

    Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706) gan Hongyun Zhao, Wenxiu Yao, Xuhong Min, Kangsheng Gu, Guohua Yu, Zhonghan Zhang, Jiuwei Cui, Liyun Miao, Li Zhang, Xia Yuan, Yong Fang, Xiuhua Fu, Chengping Hu, Xiaoli Zhu, Yun Fan, Qitao Yu, Gang Wu, Ou Jiang, DU Xiu-ping, Jiwei Liu, Wei Gu, Zhiguo Hou, Quanren Wang, Rongrong Zheng, Xianfeng Zhou, Li Zhang

    Cyhoeddwyd 2021
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease

    International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease gan Chengzhi Zhou, Yinyin Qin, Wei Zhao, Zhenyu Liang, Min Li, Dan Liu, Li Bai, Yahong Chen, Yan Chen, Yuan Cheng, Tianqing Chu, Qian Chu, Haiyi Deng, Yuchao Dong, Wen‐Feng Fang, Xiuhua Fu, Beili Gao, Yiping Han, Yong He, Qunying Hong, Jie Hu, Yi Hu, Liyan Jiang, Yang Jin, Fen Lan, Qiang Li, Shuben Li, Wen Li, Yaqing Li, Wenhua Liang, Gen Lin, Xinqing Lin, Ming Liu, Xiaofang Liu, Xiaoju Liu, Zhefeng Liu, Tangfeng Lv, Chuanyong Mu, Ming Ouyang, Jianwen Qin, Shengxiang Ren, Huan‐Zhong Shi, Minhua Shi, Chunxia Su, J. Su, Dejun Sun, Yongchang Sun, Huaping Tang, Huijuan Wang, Kai Wang, Ke Wang, Mengzhao Wang, Qi Wang, Wei Wang, Xiaoping Wang, Yuehong Wang, Zhijie Wang, Z. Wang, Lin Wu, Di Wu, Baosong Xie, Min Xie, Xiaohong Xie, Zhanhong Xie, Shufeng Xu, Xiaoman Xu, Xia Yang, Yan Yin, Zongyang Yu, Jian Zhang, Jianqing Zhang, Jing Zhang, Xiaoju Zhang, Yingying Zhang, Diansheng Zhong, Qing Zhou, Xiangdong Zhou, Yanbin Zhou, Bo Zhu, Zheng-Fei Zhu, Chenxi Zou, Nanshan Zhong, Jianxing He, Chunxue Bai, Chengping Hu, Weimin Li, Yong Song, Jianying Zhou, Baohui Han, János Varga, Esther Barreiro, Hye Yun Park, Francesco Petrella, Yuichi Saito, Taichiro Goto, Hitoshi Igai, Sara Bravaccini, Michele Zanoni, Piergiorgio Solli, Satoshi Watanabe

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Pamrevlumab for Idiopathic Pulmonary Fibrosis

    Pamrevlumab for Idiopathic Pulmonary Fibrosis gan Ganesh Raghu, Luca Richeldi, Evans R. Fernández Pérez, María Cristina De Salvo, Rafael S. Silva, Jin Woo Song, Takashi Ogura, Zuo Jun Xu, Elizabeth A. Belloli, Xueping Zhang, Lorilyn L. Seid, Lona Poole, Simon Bowler, Tamera J. Corte, Mark Holmes, Francis Thien, John Wheatley, Choi Sun-Mi, Man-Pyo Chung, Sung-Hwan Jeong, Yonghyun Kim, Eunjoo Lee, Hyun-Kyung Lee, Choon‐Sik Park, Jong Sun Park, Joo Hun Park, David Lam, Ming-Cheng Chan, Kang‐Yun Lee, Jie Cao, Xinguang Chen, Rongchang Chen, Huaping Dai, Xiuhua Fu, Zongan Liang, Qun Luo, Guochao Shi, Zhaohui Tong, Limin Wang, Shuanying Yang, Hongtao Yu, Huilan Zhang, Jianchu Zhang, Hui Zhao, Wei Wang, Ying Meng, Hong Peng, Murali Ramaswamy, Michael R. Hamblin, John Fitzgerald, Nishant Gupta, Jane E. Dematte, Srihari Veeraraghavan, Thomas O’Brien, Tracy Luckhardt, Lisa Lancaster, M. Kokoszynska, Neil Ettinger, Thomas D. Kaelin, Ather Siddiqi, Bridget F. Collins, Mary Beth Scholand, Danielle Antin‐Ozerkis, Kim Hyun, Christopher Harden, Frank Averill, Jorge M. Mallea, Rebecca Bascom, Vandana Seeram, Amy Hajari Case, E. James Britt, Barry S. Shea, Gerard J. Criner, Mark H. Gotfried, Yolanda Mageto, Sherif El Bayadi, Cristina Reichner, Joshua J. Mooney, David Hotchkin, Rodeo Abrencillo, R. Boente, Joyce Lee, Alan Betensley, Niranjan Jeganathan, Rajat Walia, Timothy Albertson, Iván O. Rosas, Dileep Puppala, Ladly Abraham, Richard I. Enelow, Nitin Bhatt, Debabratra Bandyopadhyay, Pedro Carlos Elias, Miguel Bergna, Gabriel Ricardo Garcia, G. De Stefano, Luis Arturo Wehbe, Alejandro Chirino, Ramón Luévanos Rojas, María Otaola

    Cyhoeddwyd 2024
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: